Gan & Lee Pharmaceuticals Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 9.87%

Gan & Lee Pharmaceuticals Co Ltd (603087) has an Asset Resilience Ratio of 9.87% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of Gan & Lee Pharmaceuticals Co Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥1.25 Billion

≈ $183.07 Million USD Cash + Short-term Investments

Total Assets

CN¥12.68 Billion

≈ $1.86 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2025)

This chart shows how Gan & Lee Pharmaceuticals Co Ltd's Asset Resilience Ratio has changed over time. See Gan & Lee Pharmaceuticals Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Gan & Lee Pharmaceuticals Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Gan & Lee Pharmaceuticals Co Ltd worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.25 Billion	9.87%
Total Liquid Assets	CN¥1.25 Billion	9.87%

Asset Resilience Insights

Limited Liquidity: Gan & Lee Pharmaceuticals Co Ltd maintains only 9.87% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Gan & Lee Pharmaceuticals Co Ltd Industry Peers by Asset Resilience Ratio

Compare Gan & Lee Pharmaceuticals Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
QITIAN Technology Group Co Ltd SHE:300061	Medical Instruments & Supplies	0.00%
Visco Vision Inc. TW:6782	Medical Instruments & Supplies	0.98%
Daxor Corporation NASDAQ:DXR	Medical Instruments & Supplies	65.10%
GETS Global Bhd KLSE:5079	Medical Instruments & Supplies	0.03%
Osteopore Ltd AU:OSX	Medical Instruments & Supplies	22.60%
Safe Orthopaedics SA PA:ALSAF	Medical Instruments & Supplies	2.20%
Ansell Ltd AU:ANN	Medical Instruments & Supplies	7.53%
Nanosonics Ltd AU:NAN	Medical Instruments & Supplies	46.84%

Annual Asset Resilience Ratio for Gan & Lee Pharmaceuticals Co Ltd (2019–2025)

The table below shows the annual Asset Resilience Ratio data for Gan & Lee Pharmaceuticals Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	11.10%	CN¥1.40 Billion ≈ $205.03 Million	CN¥12.63 Billion ≈ $1.85 Billion	-1.36pp
2024-12-31	12.46%	CN¥1.50 Billion ≈ $219.57 Million	CN¥12.04 Billion ≈ $1.76 Billion	-8.12pp
2023-12-31	20.58%	CN¥2.41 Billion ≈ $352.72 Million	CN¥11.72 Billion ≈ $1.71 Billion	+5.15pp
2022-12-31	15.42%	CN¥1.64 Billion ≈ $239.39 Million	CN¥10.61 Billion ≈ $1.55 Billion	+0.46pp
2021-12-31	14.97%	CN¥1.62 Billion ≈ $237.67 Million	CN¥10.85 Billion ≈ $1.59 Billion	+6.69pp
2020-12-31	8.28%	CN¥787.05 Million ≈ $115.17 Million	CN¥9.51 Billion ≈ $1.39 Billion	-9.28pp
2019-12-31	17.56%	CN¥1.06 Billion ≈ $154.86 Million	CN¥6.03 Billion ≈ $881.89 Million	--

pp = percentage points

About Gan & Lee Pharmaceuticals Co Ltd

SHG:603087 China Medical Instruments & Supplies

Market Cap

$4.79 Billion

CN¥32.75 Billion CNY

Market Cap Rank

#3722 Global

#560 in China

Share Price

CN¥54.83

Change (1 day)

-2.96%

52-Week Range

CN¥52.05 - CN¥79.62

All Time High

CN¥201.77